Princeton, New Jersey 08540

  • Trauma

Purpose:

This study is conducted in North America. The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic brain injury.


Criteria:

Inclusion Criteria: - Ages Eligible for Study: 18 Years - 85 Years


NCT ID:

NCT00124293


Primary Contact:

Study Director
Brett Skolnick, PhD
Novo Nordisk


Backup Contact:

N/A


Location Contact:

Princeton, New Jersey 08540
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.